Ascend Wellness Holdings (AAWH) Capital Expenditures (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Capital Expenditures came in at $5.2 million in Q1 2026, up 31.21% year-on-year from $3.9 million in Q1 2025, and up 130.53% quarter-over-quarter from -$17.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Capital Expenditures (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Capital Expenditures history runs 7 years deep, the most recent figure standing at $5.2 million for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 31.21% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $3.4 million, a 87.12% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 90.47% from the prior year.
- Capital Expenditures grew to $5.2 million in Q1 2026 per AAWH's latest filing, from -$17.0 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $21.8 million in Q4 2024 and bottomed at -$17.0 million in Q4 2025.
- The 5-year median for Capital Expenditures is $541000.0 (2024), against an average of $2.5 million.
- Across the five-year window, Capital Expenditures surged 95400.0% in 2023 and tumbled 177.92% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $7.0 million in 2022, then slumped by 105.19% to -$364000.0 in 2023, then jumped by 6082.14% to $21.8 million in 2024, then tumbled by 177.92% to -$17.0 million in 2025, then soared by 130.53% to $5.2 million in 2026.
- Per Business Quant, the three latest AAWH Capital Expenditures figures stand at $5.2 million (Q1 2026), -$17.0 million (Q4 2025), and $6.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 5.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.18 Mn |
| Mar 31, 2026 | 5.18 Mn |
| Dec 31, 2025 | -16.97 Mn |
| Dec 31, 2025 | -16.97 Mn |
| Sep 30, 2025 | 6.45 Mn |
| Sep 30, 2025 | 6.45 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Mar 31, 2025 | 3.95 Mn |
| Mar 31, 2025 | 3.95 Mn |
| Dec 31, 2024 | 21.78 Mn |
| Dec 31, 2024 | 21.78 Mn |
| Sep 30, 2024 | 541,000.00 |
| Sep 30, 2024 | 541,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Mar 31, 2024 | 241,000.00 |
| Mar 31, 2024 | 241,000.00 |
| Dec 31, 2023 | -364,000.00 |
| Dec 31, 2023 | -364,000.00 |